NOVOZYMES A/S earnings
Annual earnings per share (EUR per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2026 | 2026-06-30 | €0.80 | €0.80 | 2026-09-02 13:17:43.590828 |
| 2025 | 2025-06-30 | €0.69 | €0.69 | 2026-09-02 13:17:43.590828 |
Revenue & profit (EUR)
| Concept | 2026 | 2025-12-31 | 2025-06-30 |
|---|---|---|---|
| Revenue | €2.24B | — | €2.10B |
| Profit for the year | €370.8M | — | €322.8M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in NOVOZYMES A/S's ESEF annual reports (source:
filings.xbrl.org).
Figures are in EUR, as reported. Not investment advice.